wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37847070-0009F459-5A17-49BD-B5D0-914DB97884CE
Q37847070-0009F459-5A17-49BD-B5D0-914DB97884CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37847070-0009F459-5A17-49BD-B5D0-914DB97884CE
Targeting angiogenesis from multiple pathways simultaneously: BIBF 1120, an investigational novel triple angiokinase inhibitor.
P2860
Q37847070-0009F459-5A17-49BD-B5D0-914DB97884CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37847070-0009F459-5A17-49BD-B5D0-914DB97884CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d97dcbfb7c5ca940b19db63766f834ae05026b81
P2860
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.